[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.125.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1985

Angiogenic Capability of Peripheral Blood Mononuclear Cells in Psoriasis

Author Affiliations

From the Departments of Dermatology (Drs Majewski, Kamiński, Jabłońska, and Powińska) and Histology (Drs Majewski, Kamiński, and Szmurło), Warsaw School of Medicine.

Arch Dermatol. 1985;121(8):1018-1021. doi:10.1001/archderm.1985.01660080072017
Abstract

• The angiogenic capability of peripheral blood mononuclear cells (MNCs) from patients with psoriasis was tested by lymphocyte-induced angiogenesis assay. The study was performed in 36 patients with psoriasis vulgaris, six with generalized pustular psoriasis of the von Zumbusch type, and five with palmo-plantar pustular psoriasis. When patients with psoriasis vulgaris were considered as a whole, no significant differences in the angiogenic capability of their MNCs could be detected, as compared with controls. However, when cases of psoriasis were classified into various types, the differences in angiogenic capability of MNCs became evident. This capability was found to be markedly increased in the active form of psoriasis vulgaris and decreased in the stationary stage of the disease. It was increased in palmo-plantar pustular psoriasis but markedly decreased in generalized pustular psoriasis of the von Zumbusch type.

(Arch Dermatol 1985;121:1018-1021)

×